Related Experiment Video
Updated: Jun 23, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral annular disjunction and high-risk profiles: a conceptual approach to risk stratification and surgical
Koji Furukawa1, Hirohito Ishii2, Shuhei Sakaguchi2
1Division of Cardiovascular Surgery, Department of Surgery, Faculty of Medicine, University of Miyazaki, 5200 Kiyotakecho Kihara, Miyazaki-City, Miyazaki, 889-1692, Japan. koji_furukawa@med.miyazaki-u.ac.jp.
Objective:
Mitral annular disjunction (MAD), frequently associated with Barlow's disease, links degenerative mitral regurgitation to postoperative ventricular arrhythmias and sudden cardiac death, even after technically successful valve repair. However, despite advances in mitral repair, the arrhythmic substrate associated with MAD remains insufficiently addressed in current surgical paradigms.
Methods:
A systematic search of PubMed and Google Scholar (2000-2025) was conducted using keywords including "mitral annular disjunction," "mitral regurgitation," "arrhythmic mitral valve prolapse," and "mitral valve surgery." Of 264 records screened, 41 peer‑reviewed articles, prioritizing high‑impact registries and surgical cohorts, were selected for synthesis.
Results:
MAD is associated with paradoxical annular curling and traction‑related myocardial remodeling, which may contribute to fibrosis through pathological stretch. Observational studies suggest that higher‑risk features-such as extensive MAD (≥ 5 mm, particularly ≥ 8.5 mm), late gadolinium enhancement, or syncope-are linked to increased arrhythmic vulnerability. Although modern repair techniques can eliminate anatomical MAD, pre‑existing substrate abnormalities may persist, and ventricular arrhythmias can still occur after technically successful repair.
Conclusions:
The extent of disjunction and the presence of associated substrate abnormalities appear to influence long‑term rhythm stability. A conceptual, hypothesis‑generating framework that integrates structural, electrical, imaging, and clinical information may help inform risk stratification. Prospective studies are needed to determine whether a risk‑stratified approach or optimized intervention timing can modify arrhythmic risk or potentially affect long‑term outcomes.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests

